Project Grant HT94252310723
Award Date
7/15/23
Completion Date
7/14/27
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award, valued at $548,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Leland Stanford Junior University (Stanford University) to conduct research on targeting the RSK protein for the treatment of pediatric acute myeloid leukemia. The award period is from September 15, 2023, to September 14, 2026. As a leading research university, Stanford University has significant experience...
This Project Grant award from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), provides $1,419,063.00 to The Leland Stanford Junior University (Stanford University) to conduct research on synaptic retinoic acid signaling in spinal cord homeostatic plasticity and mechanical allodynia. The research, which will take place at Stanford University from September 1, 2023 to August 31, 2027, aims to transform healthcare for U.S. Service Members and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,225,171 to The Leland Stanford Junior University to conduct research on the early detection of kidney cancer using tumor-educated platelets. The performance period for this award runs from August 1, 2024 to July 31, 2028. As a leading private research institution, Stanford University will leverage its expertise in medicine, engineering, and...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $1,795,499 project grant to The Leland Stanford Junior University, doing business as Stanford University, to conduct an evaluation of clinical responders with advanced triple-negative breast cancer from the KEYNOTE-890 study. The purpose of this 4-year project is to validate a published CXCR3 gene signature that may help identify patients likely to respond to certain cancer...
This federal Project Grant award for $4,232,760.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, is funding research by The Leland Stanford Junior University (Stanford University) to advance cure rates for infantile acute lymphoblastic leukemia. The award has a performance period from June 1, 2025 to May 31, 2029. Stanford University, a private research institution, will be conducting this advanced biomedical...
The Leland Stanford Junior University has been awarded a $1,291,660.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on May 15, 2024, will fund foundational studies to understand phenotypic, region-specific, and cell-specific dysregulation in the myotonic dystrophy central nervous system, with a period of performance through May 14, 2028. This federal grant award supports the university's expertise in...
The Leland Stanford Junior University was awarded a $4.72 million Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from March 2021 through March 2025 relating the interplay of tumor function and host response to clinical outcome in triple negative breast cancer. Through this award, Stanford University researchers will investigate medical solutions for breast cancer on the battlefield and...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $430,513.00 to The Leland Stanford Junior University (Stanford University) to fund research on "Understanding How Vascular Endothelial Cells Regulate Fibroblast Functions in Pancreatitis." The research aims to investigate innovative approaches to disease prevention, diagnosis, treatment, and management for conditions...
The Leland Stanford Junior University received a $157,700 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will support research utilizing the immune response to tumor neoantigens for kidney cancer early detection. Through April 2022, Stanford University researchers will investigate medical solutions for the battlefield by exploring the potential of the body's immune response to detect and...
The Defense Health Agency awarded The Leland Stanford Junior University a $1,500,084 project grant under the Military Medical Research and Development program to support research on detecting cartilage surface degeneration using photon counting CT and solute transport modeling. This grant will fund research from July 1, 2023 through June 30, 2027 aimed at transforming military and public health care through innovative medical solutions applicable to battlefield conditions. The Military Medical...